AMITA MADAN: Open Payments
NPI 1114532538 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,794 in 94 payments from 11 companies in 2025. Trend: 2023 $1,785 · 2024 $1,393 · 2025 $1,794
Food & beverage: $1,794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $370 |
| Indivior Inc. | 8 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $193 |
| Teva Pharmaceuticals USA, Inc. | 6 | $191 |
| Otsuka America Pharmaceutical, Inc. | 11 | $182 |
| Alkermes, Inc. | 9 | $176 |
| E.R. Squibb & Sons, L.L.C. | 13 | $150 |
| Janssen Pharmaceuticals, Inc | 7 | $145 |
| Axsome Therapeutics, Inc. | 7 | $115 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
Products named: VRAYLAR, SUBLOCADE, CAPLYTA, UZEDY, COBENFY, ARISTADA, INVEGA SUSTENNA, Auvelity.
Industry payments across MI — which companies pay providers there.
